Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 118,796 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 16,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 6,630 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 225,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | UTENDR | 16,405 | — | — | -100.0% | Open the original filing on SEC.gov |